William Schary
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Toxicology top 10%
Papers in
- Genetics 9
- Chronic Lymphocytic Leukemia Research 9
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Malcolm Rowland (6 shared papers)Kenneth K. Chan (1 shared paper)Richard J. Lewis (1 shared paper)William Trager (1 shared paper)Arthur B. Straughn (2 shared papers)AM Breckenridge (1 shared paper)M. Orme (1 shared paper)Ming Lo (1 shared paper)
- Journals
- Blood (3 papers)The Journal of Clinical Pharmacology (3 papers)European Journal of Clinical Pharmacology (2 papers)HemaSphere (2 papers)Journal of Pharmacy and Pharmacology (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
William Schary
25 papers receiving 575 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 213
- Toxicology 29
- Pharmacology 98
- Pharmaceutical Science 36
- Genetics 53
Countries citing papers authored by William Schary
This map shows the geographic impact of William Schary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Schary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Schary more than expected).
Fields of papers citing papers by William Schary
This network shows the impact of papers produced by William Schary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Schary. The network helps show where William Schary may publish in the future.
Co-authors
The 25 scholars most cited alongside William Schary, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 211 | |
| 2 | Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration. | 1984 | 145 |
| 3 | 1983 | 44 | |
| 4 | 1987 | 32 | |
| 5 | 1976 | 30 | |
| 6 | 1987 | 21 | |
| 7 | 2020 | 20 | |
| 8 | 1979 | 18 | |
| 9 | Warfarin-phenylbutazone interaction in man: a long term multiple dose study. | 1975 | 16 |
| 10 | 1987 | 13 | |
| 11 | 1984 | 9 | |
| 12 | 1992 | 8 | |
| 13 | 2023 | 8 | |
| 14 | 2018 | 7 | |
| 15 | 1978 | 7 | |
| 16 | 1984 | 7 | |
| 17 | 2019 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2020 | 4 | |
| 20 | Bioavailability of oral and intramuscular molindone hydrochloride in schizophrenic patients. | 1985 | 4 |
About William Schary
William Schary is a scholar working on Genetics, Pharmacology, Pathology and Forensic Medicine, Pharmacology and Oncology, having authored 26 papers that have together received 624 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Pharmacogenetics and Drug Metabolism (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Cardiac electrophysiology and arrhythmias (2 papers). The work is most often cited by research in Pharmacology (213 citations), Toxicology (29 citations), Pharmacology (98 citations), Pharmaceutical Science (36 citations) and Genetics (53 citations). William Schary has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Malcolm Rowland, Kenneth K. Chan, Richard J. Lewis, William Trager, Arthur B. Straughn, AM Breckenridge, M. Orme, Ming Lo, Michele C. Meyer and Man‐Wai Lo. Their work appears in journals such as Blood, The Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, HemaSphere and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.